2004
DOI: 10.1227/01.neu.0000108982.26949.f7
|View full text |Cite
|
Sign up to set email alerts
|

Cerebellar Malignant Fibrous Histiocytoma: Case Report and Literature Review

Abstract: Malignant fibrous histiocytoma is still a controversial entity, and the lack of specific criteria means that it must be diagnosed via the process of elimination. With currently available therapy, our review can provide only a very poor prognosis. The median survival time was 27 months. In attempts to develop better therapeutic strategies, total excision and radiotherapy seem to represent the best treatment approach.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 53 publications
1
10
0
Order By: Relevance
“…Hamlat et al, presented 49 reported intracranial pleomorphic sarcomas [8]. They found that UPS may occur at any age and with no sex predominance.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hamlat et al, presented 49 reported intracranial pleomorphic sarcomas [8]. They found that UPS may occur at any age and with no sex predominance.…”
Section: Discussionmentioning
confidence: 99%
“…It would, therefore, seem logical that adjuvant radiotherapy would demonstrate a survival benefit; however, the optimal dose has not yet been proven. Even with aggressive chemotherapy and radiation, median survival was only 27 months due to local progression with occasional metastasis and cerebrospinal fluid dissemination according to Hamlat et al’s series [8]. Doxorubicin and ifosfamide have been used in the treatment of intracranial UPS due to their activity against soft tissue sarcomas as reported by Akimoto et al [9].…”
Section: Discussionmentioning
confidence: 99%
“…MFHs account for 10.5%-21.6% of all malignant neoplasias of soft tissue [20] . MFHs in the central nervous system are extremely rare, but have been reported in the brain, dura mater, and spine [5] . Some MFHs arising from the skull bones or subcutaneous tissues can also extend into the cranial cavity [21][22][23] .…”
Section: Discussionmentioning
confidence: 99%
“…In 2004, Hamlat et al [5] performed a complete review of intracranial MFH reports published before 2003.…”
Section: Literature Review and Survival Analysismentioning
confidence: 99%
“…Brain metastases arise in less than 0.2% of patients with systemic soft tissue sarcomas, but may be more frequent in patients with systemic MFH (4 out of 40 cases in one large case series) [2]. MFH can rarely arise primarily within the CNS and take cystic forms [3]. MFH has been reported to arise within the heart and produce multiple cerebral metastases [4].…”
Section: Discussionmentioning
confidence: 99%